OpenVSafe by OpenVAERS
Search V-safe

U2H-29445-76740

3 vaccinations 1 coded response 8 check-ins 0 free-text entries 0 call cases
Sex
Female
Age at first dose
05-11
ZIP prefix
606 / IL
Registered
2022-05-02
Relationship
Child or adolescent in my care
Guardian
DL4-36073-02996
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-12-01
    Dose 1 — Pfizer-BioNTech
  2. 2021-12-22
    Dose 2 — Pfizer-BioNTech
  3. 2022-05-02
    Registered in v-safe
  4. 2022-06-21
    Dose 3 — Pfizer-BioNTech
  5. 2022-06-24
  6. 2022-07-15
    Health check-in — day 21, dose 3, dependent
    Feeling: Good
    Adult check-in
  7. 2022-07-19
    Health check-in — day 28, dose 3, dependent
    Feeling: Good
    Adult check-in
  8. 2022-07-26
    Health check-in — day 35, dose 3, dependent
    Feeling: Good
    Adult check-in
  9. 2022-08-02
    Health check-in — day 42, dose 3, dependent
    Feeling: Good
    Adult check-in
  10. 2022-09-23
  11. 2022-12-21
  12. 2023-06-21
    Survey response — 12 months, dose 3, dependent
    MedDRA: Anxiety, Attention deficit hyperactivity disorder — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    MedDRA releases: 2024-11

Vaccinations

DoseDateManufacturerCo-administered
12021-12-01Pfizer-BioNTech No
22021-12-22Pfizer-BioNTech No
32022-06-21Pfizer-BioNTech No

Free text

None.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAnxiety · · ✓
SDAttention deficit hyperactivity disorder · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…